AU8961382A
(en)
*
|
1981-11-06 |
1983-05-12 |
Imperial Chemical Industries Plc |
Amide derivatives
|
GB8504093D0
(en)
*
|
1985-02-18 |
1985-03-20 |
Ici Plc |
Alkene alkyne/cycloalkylene derivatives
|
US5236953A
(en)
*
|
1982-04-14 |
1993-08-17 |
Imperial Chemical Industries Plc |
Alkene, alkyne or cycloalkylene derivatives
|
US4518789A
(en)
*
|
1982-06-30 |
1985-05-21 |
Yu Ruey J |
Phenyl alpha-acyloxyacetamide derivatives and their therapeutic use
|
EP0100172B1
(en)
*
|
1982-07-23 |
1987-08-12 |
Imperial Chemical Industries Plc |
Amide derivatives
|
US4536346A
(en)
*
|
1983-05-06 |
1985-08-20 |
American Cyanamid Company |
Aralkanamidophenyl compounds
|
JPS60136546A
(ja)
*
|
1983-12-26 |
1985-07-20 |
Yashima Chem Ind Co Ltd |
置換フエニル酢酸アニリド誘導体、その製法及び用途
|
GB8406000D0
(en)
*
|
1984-03-07 |
1984-04-11 |
Ici Plc |
Olefine derivatives
|
US4666885A
(en)
*
|
1985-02-08 |
1987-05-19 |
Fernand Labrie |
Combination therapy for treatment of female breast cancer
|
US4760053A
(en)
*
|
1984-08-02 |
1988-07-26 |
Fernand Labrie |
Combination therapy for selected sex steroid dependent cancers
|
GB8617653D0
(en)
*
|
1986-07-18 |
1986-08-28 |
Ici Plc |
Amide derivatives
|
GB8617652D0
(en)
*
|
1986-07-18 |
1986-08-28 |
Ici Plc |
Acylanilide derivatives
|
US4921941A
(en)
*
|
1987-07-01 |
1990-05-01 |
Schering Corporation |
Orally active antiandrogens
|
US4895715A
(en)
*
|
1988-04-14 |
1990-01-23 |
Schering Corporation |
Method of treating gynecomastia
|
US5204337A
(en)
*
|
1988-10-31 |
1993-04-20 |
Endorecherche Inc. |
Estrogen nucleus derivatives for use in inhibition of sex steroid activity
|
US5364847A
(en)
*
|
1989-03-10 |
1994-11-15 |
Endorecherche |
Inhibitors of sex steroid biosynthesis and methods for their production and use
|
US5372996A
(en)
*
|
1989-03-10 |
1994-12-13 |
Endorecherche, Inc. |
Method of treatment of androgen-related diseases
|
JP2959839B2
(ja)
*
|
1989-07-07 |
1999-10-06 |
アンドルシェルシュ・インコーポレイテッド |
性ステロイド活性の抑制における使用のためのアンドロゲン誘導体
|
KR920703065A
(ko)
*
|
1989-07-07 |
1992-12-17 |
원본미기재 |
안드로겐 관련질병의 치료방법
|
US5260292A
(en)
*
|
1991-03-05 |
1993-11-09 |
Marvin S. Towsend |
Topical treatment of acne with aminopenicillins
|
ZA924811B
(en)
*
|
1991-06-28 |
1993-12-29 |
Endorecherche Inc |
Controlled release systems and low dose androgens
|
GB9214120D0
(en)
*
|
1991-07-25 |
1992-08-12 |
Ici Plc |
Therapeutic amides
|
AU4258493A
(en)
*
|
1992-05-21 |
1993-12-13 |
Endorecherche Inc. |
Inhibitors of testosterone 5alpha-reductase activity
|
GB9305295D0
(en)
*
|
1993-03-15 |
1993-05-05 |
Zeneca Ltd |
Therapeutic compounds
|
GB9310095D0
(en)
*
|
1993-05-17 |
1993-06-30 |
Zeneca Ltd |
Therapeutic compounds
|
WO1996000090A1
(en)
*
|
1994-06-27 |
1996-01-04 |
Ionix Corporation |
Boron-containing hormone analogs and methods of their use in imaging or killing cells having hormone receptors
|
FR2745717B1
(fr)
*
|
1996-03-06 |
1998-04-17 |
Oreal |
Utilisation de n-aryl-2-hydroxyalkylamides pour stimuler ou induire la pousse des cheveux et/ou stopper leur chute
|
US6291532B1
(en)
|
1996-03-06 |
2001-09-18 |
L'oreal |
Use of N-aryl-2-hydroxyalkylamides for stimulating or inducing hair growth and/or arresting hair loss
|
US6492554B2
(en)
|
2000-08-24 |
2002-12-10 |
The University Of Tennessee Research Corporation |
Selective androgen receptor modulators and methods of use thereof
|
US6071957A
(en)
|
1996-11-27 |
2000-06-06 |
The University Of Tennessee Research Corporation |
Irreversible non-steroidal antagonist compound and its use in the treatment of prostate cancer
|
US7759520B2
(en)
|
1996-11-27 |
2010-07-20 |
University Of Tennessee Research Foundation |
Synthesis of selective androgen receptor modulators
|
US20050038110A1
(en)
*
|
2000-08-24 |
2005-02-17 |
Steiner Mitchell S. |
Selective androgen receptor modulators and methods of use thereof
|
US6995284B2
(en)
|
2000-08-24 |
2006-02-07 |
The University Of Tennessee Research Foundation |
Synthesis of selective androgen receptor modulators
|
US7518013B2
(en)
|
2000-08-24 |
2009-04-14 |
University Of Tennessee Research Foundation |
Selective androgen receptor modulators
|
US6245804B1
(en)
|
1997-05-30 |
2001-06-12 |
Schering Aktiengesellschaft |
Nonsteroidal gestagens
|
US6160011A
(en)
*
|
1997-05-30 |
2000-12-12 |
The University Of Tennessee Research Corporation |
Non-steroidal agonist compounds and their use in male hormone therapy
|
DE19723722A1
(de)
*
|
1997-05-30 |
1998-12-10 |
Schering Ag |
Nichtsteroidale Gestagene
|
WO1998055153A1
(en)
*
|
1997-06-04 |
1998-12-10 |
The University Of Tennessee Research Corporation |
Non-steroidal radiolabeled agonist/antagonist compounds and their use in prostate cancer imaging
|
GB9804648D0
(en)
|
1998-03-06 |
1998-04-29 |
Zeneca Ltd |
Chemical compounds
|
GB9805520D0
(en)
|
1998-03-17 |
1998-05-13 |
Zeneca Ltd |
Chemical compounds
|
US20040176470A1
(en)
*
|
1998-05-07 |
2004-09-09 |
Steiner Mitchell S. |
Method for treatment and chemoprevention of prostate cancer
|
GB9811427D0
(en)
|
1998-05-29 |
1998-07-22 |
Zeneca Ltd |
Chemical compounds
|
US6878712B1
(en)
|
1999-09-04 |
2005-04-12 |
Astrazeneca Ab |
Amides as inhibitors for pyruvate dehydrogenase
|
HUP0202725A3
(en)
|
1999-09-04 |
2005-04-28 |
Astrazeneca Ab |
Substituted n-phenyl 2-hydroxy-2-methyl-3,3,3-trifluoropropanamide derivatives which elevate pyruvate dehydrogenase activity, process for their preparation and pharmaceutical compositions containing them
|
US6552225B1
(en)
|
1999-09-04 |
2003-04-22 |
Astrazeneca Ab |
Chemical compounds
|
US8445534B2
(en)
|
2000-08-24 |
2013-05-21 |
University Of Tennessee Research Foundation |
Treating androgen decline in aging male (ADAM)-associated conditions with SARMs
|
US6838484B2
(en)
|
2000-08-24 |
2005-01-04 |
University Of Tennessee Research Foundation |
Formulations comprising selective androgen receptor modulators
|
US20040260108A1
(en)
*
|
2001-06-25 |
2004-12-23 |
Dalton James T. |
Metabolites of selective androgen receptor modulators and methods of use thereof
|
GEP20053586B
(en)
|
2000-08-24 |
2005-07-25 |
Univ Tennessee Res Corp |
Selective Androgen Receptor Modulators and Pharmaceutical Compositions Containing the Same
|
US7026500B2
(en)
|
2000-08-24 |
2006-04-11 |
University Of Tennessee Research Foundation |
Halogenated selective androgen receptor modulators and methods of use thereof
|
US7547728B2
(en)
|
2001-12-06 |
2009-06-16 |
University Of Tennessee Research Foundation |
Treating muscle wasting with selective androgen receptor modulators
|
US7645898B2
(en)
|
2000-08-24 |
2010-01-12 |
University Of Tennessee Research Foundation |
Selective androgen receptor modulators and method of use thereof
|
US20070173546A1
(en)
*
|
2000-08-24 |
2007-07-26 |
Dalton James T |
Selective androgen receptor modulators and method of use thereof
|
US8008348B2
(en)
|
2001-12-06 |
2011-08-30 |
University Of Tennessee Research Foundation |
Treating muscle wasting with selective androgen receptor modulators
|
US6998500B2
(en)
|
2000-08-24 |
2006-02-14 |
University Of Tennessee Research Foundation |
Selective androgen receptor modulators and methods of use thereof
|
US7622503B2
(en)
|
2000-08-24 |
2009-11-24 |
University Of Tennessee Research Foundation |
Selective androgen receptor modulators and methods of use thereof
|
US7919647B2
(en)
|
2000-08-24 |
2011-04-05 |
University Of Tennessee Research Foundation |
Selective androgen receptor modulators and methods of use thereof
|
US7855229B2
(en)
|
2000-08-24 |
2010-12-21 |
University Of Tennessee Research Foundation |
Treating wasting disorders with selective androgen receptor modulators
|
US20060287282A1
(en)
*
|
2001-06-25 |
2006-12-21 |
Steiner Mitchell S |
Compositions comprising a SARM ad GnRH agonist or a GnRH antagonist, and methods of use thereof
|
AU2002322493A1
(en)
*
|
2001-07-10 |
2003-01-29 |
Ams Research Corporation |
Surgical kit for treating prostate tissue
|
US8853266B2
(en)
|
2001-12-06 |
2014-10-07 |
University Of Tennessee Research Foundation |
Selective androgen receptor modulators for treating diabetes
|
US20070161608A1
(en)
*
|
2001-12-06 |
2007-07-12 |
Dalton James T |
Selective androgen receptor modulators for treating muscle wasting
|
KR101032661B1
(ko)
|
2002-02-07 |
2011-05-06 |
유니버시티 오브 테네시 리서치 파운데이션 |
선택적 안드로겐 수용체 조절자를 이용한 양성 전립선과형성증의 치료 방법
|
US7803970B2
(en)
|
2002-02-28 |
2010-09-28 |
University Of Tennessee Research Foundation |
Multi-substitued selective androgen receptor modulators and methods of use thereof
|
CN1639110A
(zh)
*
|
2002-02-28 |
2005-07-13 |
田纳西大学研究基金会 |
卤代乙酰胺和叠氮化物取代的化合物及其使用方法
|
EP1487458B1
(en)
|
2002-02-28 |
2011-11-16 |
University Of Tennessee Research Foundation |
Multi-substituted selective androgen receptor modulators and methods of use thereof
|
US7772433B2
(en)
|
2002-02-28 |
2010-08-10 |
University Of Tennessee Research Foundation |
SARMS and method of use thereof
|
AU2003217304A1
(en)
|
2002-02-28 |
2003-09-16 |
The University Of Tennessee Research Corporation |
Radiolabeled selective androgen receptor modulators and their use in prostate cancer imaging and therapy
|
MXPA04013001A
(es)
|
2002-06-17 |
2005-09-12 |
Univ Tennessee Res Foundation |
Moduladores del receptor de androgneo selectivo en fuente n y metodos de uso de los mismos.
|
US7741371B2
(en)
|
2002-06-17 |
2010-06-22 |
University Of Tennessee Research Foundation |
Selective androgen receptor modulators and methods of use thereof
|
AU2003287075A1
(en)
*
|
2002-10-15 |
2004-05-04 |
Gtx, Inc. |
Treating obesity with selective androgen receptor modulators
|
US20040197928A1
(en)
*
|
2002-10-15 |
2004-10-07 |
Dalton James T. |
Method for detecting selective androgen receptor modulators
|
WO2004035738A2
(en)
*
|
2002-10-15 |
2004-04-29 |
University Of Tennessee Research Foundation |
Methylene-bridged selective androgen receptor modulators and methods of use thereof
|
JP2006505564A
(ja)
*
|
2002-10-16 |
2006-02-16 |
ジーティーエックス・インコーポレイテッド |
Sarmによる高齢男性のアンドロゲン減少に関連する病気の治療
|
US20060276539A1
(en)
*
|
2002-10-16 |
2006-12-07 |
Dalton James T |
Treating Androgen Decline in Aging Male (ADAM)- associated conditions with SARMS
|
US20040087810A1
(en)
*
|
2002-10-23 |
2004-05-06 |
Dalton James T. |
Irreversible selective androgen receptor modulators and methods of use thereof
|
US8309603B2
(en)
|
2004-06-07 |
2012-11-13 |
University Of Tennessee Research Foundation |
SARMs and method of use thereof
|
US20040167103A1
(en)
*
|
2003-02-24 |
2004-08-26 |
Dalton James T. |
Haloacetamide and azide substituted compounds and methods of use thereof
|
JP2007513998A
(ja)
|
2003-12-16 |
2007-05-31 |
ジーティーエックス・インコーポレイテッド |
選択的アンドロゲン受容体調節剤のプロドラッグ及びその使用方法
|
CA2561525A1
(en)
|
2004-04-14 |
2005-11-24 |
Amgen, Inc. |
Aryl sulfones and uses related thereto
|
US9884038B2
(en)
|
2004-06-07 |
2018-02-06 |
University Of Tennessee Research Foundation |
Selective androgen receptor modulator and methods of use thereof
|
US20110237664A1
(en)
*
|
2004-06-07 |
2011-09-29 |
Dalton James T |
Selective androgen receptor modulators for treating diabetes
|
US9889110B2
(en)
|
2004-06-07 |
2018-02-13 |
University Of Tennessee Research Foundation |
Selective androgen receptor modulator for treating hormone-related conditions
|
US20060258628A1
(en)
*
|
2004-07-20 |
2006-11-16 |
Steiner Mitchell S |
Compositions comprising 5-alpha reductase inhibitors, and SARMs and methods of use thereof
|
US9844528B2
(en)
|
2006-08-24 |
2017-12-19 |
University Of Tennessee Research Foundation |
SARMs and method of use thereof
|
US9730908B2
(en)
|
2006-08-24 |
2017-08-15 |
University Of Tennessee Research Foundation |
SARMs and method of use thereof
|
US10010521B2
(en)
|
2006-08-24 |
2018-07-03 |
University Of Tennessee Research Foundation |
SARMs and method of use thereof
|
AU2007287070C1
(en)
|
2006-08-24 |
2013-02-14 |
University Of Tennessee Research Foundation |
Substituted acylanilides and methods of use thereof
|
US9232959B2
(en)
|
2007-01-02 |
2016-01-12 |
Aquabeam, Llc |
Multi fluid tissue resection methods and devices
|
EP2099375B1
(en)
|
2007-01-02 |
2014-09-24 |
AquaBeam LLC |
Minimally invasive devices for the treatment of prostate diseases
|
US20080245375A1
(en)
*
|
2007-04-05 |
2008-10-09 |
Medtronic Vascular, Inc. |
Benign Prostatic Hyperplasia Treatments
|
US7968603B2
(en)
|
2007-09-11 |
2011-06-28 |
University Of Tennessee Research Foundation |
Solid forms of selective androgen receptor modulators
|
JP5535925B2
(ja)
|
2007-10-26 |
2014-07-02 |
ザ リージェンツ オブ ザ ユニバーシティ オブ カリフォルニア |
アンドロゲン受容体調節物質としてのジアリールヒダントイン化合物
|
EP3622910B1
(en)
|
2008-03-06 |
2024-07-10 |
AquaBeam LLC |
Tissue ablation and cautery with optical energy carried in fluid stream
|
US9848904B2
(en)
|
2009-03-06 |
2017-12-26 |
Procept Biorobotics Corporation |
Tissue resection and treatment with shedding pulses
|
WO2016004071A1
(en)
|
2014-06-30 |
2016-01-07 |
Procept Biorobotics Corporation |
Fluid jet tissue resection and cold coagulation (aquablation) methods and apparatus
|
JP2014510045A
(ja)
|
2011-02-08 |
2014-04-24 |
ハロザイム インコーポレイテッド |
ヒアルロナン分解酵素の組成物および脂質製剤ならびに良性前立腺肥大症の治療のためのその使用
|
US9161924B2
(en)
|
2011-07-08 |
2015-10-20 |
Merck Sharp & Dohme Corp. |
Factor IXa inhibitors
|
CN104203078B
(zh)
|
2012-02-29 |
2018-04-20 |
普罗赛普特生物机器人公司 |
自动化图像引导的组织切除和处理
|
US10987334B2
(en)
|
2012-07-13 |
2021-04-27 |
University Of Tennessee Research Foundation |
Method of treating ER mutant expressing breast cancers with selective androgen receptor modulators (SARMs)
|
US9969683B2
(en)
|
2012-07-13 |
2018-05-15 |
Gtx, Inc. |
Method of treating estrogen receptor (ER)-positive breast cancers with selective androgen receptor modulator (SARMS)
|
US10314807B2
(en)
|
2012-07-13 |
2019-06-11 |
Gtx, Inc. |
Method of treating HER2-positive breast cancers with selective androgen receptor modulators (SARMS)
|
US9744149B2
(en)
|
2012-07-13 |
2017-08-29 |
Gtx, Inc. |
Method of treating androgen receptor (AR)-positive breast cancers with selective androgen receptor modulator (SARMs)
|
JP6226978B2
(ja)
|
2012-07-13 |
2017-11-08 |
ジーティーエックス・インコーポレイテッド |
選択的アンドロゲン受容体モジュレーター(sarm)によりアンドロゲン受容体(ar)陽性乳癌を処置する方法
|
US10258596B2
(en)
|
2012-07-13 |
2019-04-16 |
Gtx, Inc. |
Method of treating HER2-positive breast cancers with selective androgen receptor modulators (SARMS)
|
US9622992B2
(en)
|
2012-07-13 |
2017-04-18 |
Gtx, Inc. |
Method of treating androgen receptor (AR)-positive breast cancers with selective androgen receptor modulator (SARMs)
|
CN105431096B
(zh)
|
2013-02-14 |
2018-07-31 |
普罗赛普特生物机器人公司 |
液体消融液体束眼外科手术的方法和装置
|
BR112016005036A2
(pt)
|
2013-09-06 |
2020-04-07 |
Procept Biorobotics Corp |
aparelho para ressecção de tecido guiada por imagem automatizada
|
CN114224438A
(zh)
|
2014-09-05 |
2022-03-25 |
普罗赛普特生物机器人公司 |
与靶器官图像的治疗映射结合的医师控制的组织切除
|